Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Recruiting Observational

Pilot Study: Feasibility and Usability of a Head-Mounted Spatial Computing Device for Intraoperative Visualization During Intraocular Surgery

NCT07825337 · tracked via the Priya Life Science USA tracker
Sponsor
Eric Rosenberg
Phase
Observational
Started
2026-08-30
Last updated
2026-09-17

Condition(s) studied

Cataract Surgery

Investigational drug(s) / intervention(s)

Apple Vision Pro Visualization System

Apple Vision Pro Visualization System: Apple Vision Pro as an adjunct intraoperative visualization and information display tool during ophthalmic surgery.\[

Study summary

To evaluate the feasibility and usability of Apple Vision Pro as an adjunct visualization and information display tool during ophthalmic surgery.

Eligibility

Sex
ALL
Min age
18 Years
Max age
90 Years
Healthy volunteers
No
Inclusion Criteria: * Adults aged 18 years or older. * Undergoing clinically indicated, elective ophthalmic surgery (e.g., cataract, anterior segment, retina) at a participating study site. * Able and willing to provide informed consent prior to participation. Exclusion Criteria: * Prisoners or other vulnerable populations, unless specifically justified and approved by the IRB. * Inability to provide consent and no legally authorized representative available. * Cognitive impairment or language barriers precluding understanding of the consent, in the absence of a legally authorized representative. * Procedures where any additional OR equipment is judged by the surgeon to pose unacceptable risk. * Complex ocular pathology that could interfere with surgical visualization or increase procedural risk, including but not limited to lenticular zonule instability, previous ophthalmic surgery, corneal scarring, corneal opacity or edema, or active ocular surface infection.

Primary outcome measure(s)

  • Continuity of care — 1 year
    Completion of surgery without device-related interruption that requires abandoning the surgery or conversion to an alternative procedure.
  • Questionnaire — 1 year
    XR Usability Questionnaire (XR-UQ) scores for each case.

Trial sites (1)

FacilityCityRegionStatus
Long Island Ambulator Surgery Center Brentwood New York Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07825337 on ClinicalTrials.gov ↗ ← All trials in the USA